SIRT3 Deacetylates Ceramide Synthases: IMPLICATIONS FOR MITOCHONDRIAL DYSFUNCTION AND BRAIN INJURY

Area of Science:

• Mitochondrial biology
• Neuroscience
• Biochemistry

Background:

• Mitochondrial ceramide accumulation is linked to brain injury post-stroke.
• Sirtuin 3 (SIRT3) is a key mitochondrial deacetylase.

Purpose of the Study:

• To investigate the role of SIRT3 in regulating mitochondrial ceramide biosynthesis.
• To elucidate the mechanism by which SIRT3 influences brain injury after ischemia/reperfusion (IR).

Main Methods:

• Reciprocal immunoprecipitation to assess protein-protein interactions.
• Analysis of ceramide synthase (CerS) acetylation in wild-type and SIRT3-null mice.
• Enzyme activity assays for CerS.
• Assessment of mitochondrial function (electron transport chain, outer membrane permeabilization, ROS generation) after IR.
• Evaluation of brain injury in Sirt3 gene-ablated mice post-IR.

Main Results:

• SIRT3 directly deacetylates and activates ceramide synthases (CerS1, CerS2, CerS6) in cerebral mitochondria.
• SIRT3-mediated activation of CerS leads to increased ceramide accumulation post-IR.
• Absence of SIRT3 protects against IR-induced mitochondrial dysfunction, including Complex III blockade and ROS generation.
• Sirt3 gene ablation reduces brain injury following experimental stroke.

Conclusions:

• SIRT3 plays a critical role in modulating mitochondrial ceramide biosynthesis.
• IR induces SIRT3-dependent ceramide elevation, contributing to mitochondrial dysfunction and brain injury.
• Targeting SIRT3 may offer a therapeutic strategy for stroke-related brain injury.